Media, PA, United States of America

Peggy Ann Scherle

USPTO Granted Patents = 6 


 

Average Co-Inventor Count = 3.5

ph-index = 3

Forward Citations = 22(Granted Patents)


Location History:

  • Media, PA (US) (2007 - 2018)
  • Swarthmore, PA (US) (2020)

Company Filing History:


Years Active: 2007-2020

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Peggy Ann Scherle

Introduction

Peggy Ann Scherle is a notable inventor based in Media, Pennsylvania, recognized for her significant contributions to the field of medical research. With a total of six patents to her name, she has made remarkable strides in the treatment of B-cell malignancies. Her work exemplifies the intersection of innovation and healthcare, showcasing her dedication to improving patient outcomes.

Latest Patents

Among her latest patents is a groundbreaking invention titled "Treatment of B-cell malignancies by a combination JAK and PI3K inhibitors." This invention focuses on methods for treating B-cell malignancies through the use of a combination of inhibitors targeting JAK1 and/or JAK2 alongside inhibitors of PI3Kδ. This innovative approach has the potential to enhance treatment efficacy for patients suffering from these malignancies.

Career Highlights

Throughout her career, Peggy has worked with prominent companies in the pharmaceutical industry, including Incyte Corporation and Bristol-Myers Squibb Company. Her experience in these organizations has allowed her to develop and refine her innovative ideas, contributing to advancements in cancer treatment.

Collaborations

Peggy has collaborated with esteemed colleagues such as Steven M. Friedman and Krishna Vaddi. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing her contributions to the field.

Conclusion

Peggy Ann Scherle's work as an inventor has significantly impacted the treatment of B-cell malignancies. Her innovative patents and collaborations reflect her commitment to advancing medical science and improving patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…